回收式自体输血在恶性肿瘤患者手术中的应用及风险评估  

Application and risk assessment of intraoperative cell salvage in patient with malignancy

作　　者：李振洲 陈雅儒[2] 郭建荣[1] LI Zhenzhou;CHEN Yaru;GUO Jianrong(Department of Anesthesiology&Perioperative Medicine,Shanghai Pudong Gongli Hospital,Naval Military Medical University,Shanghai 200135,China;General Hospital of Ningxia Medical University)

机构地区：[1]海军军医大学附属公利医院麻醉与围术期医学部,上海200135 [2]宁夏医科大学总医院

出　　处：《中国输血杂志》2022年第3期345-348,共4页Chinese Journal of Blood Transfusion

基　　金：上海市浦东新区卫生系统重点学科群建设项目(PWZxq2017-10);上海市浦东新区卫生健康委新兴交叉学科建设项目(PWXx2020-05)。

摘　　要：恶性肿瘤患者常需大量输血。过去出于对肿瘤细胞再输注的担忧,回收式自体输血在恶性肿瘤患者手术中的应用受限。但随着回收式自体输血在恶性肿瘤手术患者中的应用与研究相关报道的不断增加,有必要对恶性肿瘤患者围术期回收式自体输血的应用进行重新评估。本文就近年来有关回收式自体输血在恶性肿瘤手术中的应用、风险和价值做一综述。Patients with malignant tumour often require massive transfusion.Intraoperative cell salvage(IOCS)was initially limited in cancer surgery by concerns about the possibility of dissemination of tumor cells into circulation.However,as supportive literature concerning IOCS research and application in cancer surgery are increasing,it is necessary to reassess the perioperative application of IOCS in patients with malignancy.This review summarizes the application,risks and value of IOCS during cancer operations.

关 键 词：回收式自体输血 恶性肿瘤 手术 风险 

分 类 号：R457.1[医药卫生—治疗学] R73[医药卫生—临床医学]